Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delphine Trochet

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|July 23, 2021
A review of Dynamin 2 involvement in cancers highlights a promising therapeutic targetDelphine Trochet, Marc Bitoun
Current Gene Therapy|August 13, 2015
Therapy for dominant inherited diseases by allele-specific RNA interference: successes and pitfallsDelphine Trochet, Bernard Prudhon, Stéphane Vassilopoulos, et al.
Molecular Therapy. Nucleic Acids|September 14, 2016
Reprogramming the Dynamin 2 mRNA by Spliceosome-mediated RNA Trans-splicingDelphine Trochet, Bernard Prudhon, Arnaud Jollet, et al.
Human Molecular Genetics|September 11, 2004
Polyalanine expansions in humanJeanne Amiel, Delphine Trochet, Mathieu Clément-Ziza, et al.
American Journal of Human Genetics|September 19, 2025
Allele-specific RNAi therapy corrects an extracellular matrix defect in Schuurs-Hoeijmakers syndromeLylia Mekzine, Natalia Pinzón, Kamel Mamchaoui, et al.
Pediatric Pulmonology|August 31, 2004
PHOX2B gene mutation in a patient with late-onset central hypoventilationHa Trang, Béatrice Laudier, Delphine Trochet, et al.
Human Mutation|June 15, 2007
Polyalanine expansions might not result from unequal crossing-overDelphine Trochet, Loïc de Pontual, Boris Keren, et al.
Molecular Therapy. Nucleic Acids|September 12, 2022
Development of versatile allele-specific siRNAs able to silence all the dominant dynamin 2 mutationsSwati Dudhal, Lylia Mekzine, Bernard Prudhon, et al.
Pediatrics|June 3, 2005
Congenital central hypoventilation syndrome and Hirschsprung's disease in an extremely preterm infantRamesh Bajaj, Janine Smith, Delphine Trochet, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2008
A human mutation in Phox2b causes lack of CO2 chemosensitivity, fatal central apnea, and specific loss of parafacial neuronsVéronique Dubreuil, Nélina Ramanantsoa, Delphine Trochet, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Experimental & Clinical Cancer Research : CR|July 23, 2021
A review of Dynamin 2 involvement in cancers highlights a promising therapeutic targetDelphine Trochet, Marc Bitoun
Current Gene Therapy|August 13, 2015
Therapy for dominant inherited diseases by allele-specific RNA interference: successes and pitfallsDelphine Trochet, Bernard Prudhon, Stéphane Vassilopoulos, et al.
Molecular Therapy. Nucleic Acids|September 14, 2016
Reprogramming the Dynamin 2 mRNA by Spliceosome-mediated RNA Trans-splicingDelphine Trochet, Bernard Prudhon, Arnaud Jollet, et al.
Human Molecular Genetics|September 11, 2004
Polyalanine expansions in humanJeanne Amiel, Delphine Trochet, Mathieu Clément-Ziza, et al.
American Journal of Human Genetics|September 19, 2025
Allele-specific RNAi therapy corrects an extracellular matrix defect in Schuurs-Hoeijmakers syndromeLylia Mekzine, Natalia Pinzón, Kamel Mamchaoui, et al.
Pediatric Pulmonology|August 31, 2004
PHOX2B gene mutation in a patient with late-onset central hypoventilationHa Trang, Béatrice Laudier, Delphine Trochet, et al.
Human Mutation|June 15, 2007
Polyalanine expansions might not result from unequal crossing-overDelphine Trochet, Loïc de Pontual, Boris Keren, et al.
Molecular Therapy. Nucleic Acids|September 12, 2022
Development of versatile allele-specific siRNAs able to silence all the dominant dynamin 2 mutationsSwati Dudhal, Lylia Mekzine, Bernard Prudhon, et al.
Pediatrics|June 3, 2005
Congenital central hypoventilation syndrome and Hirschsprung's disease in an extremely preterm infantRamesh Bajaj, Janine Smith, Delphine Trochet, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2008
A human mutation in Phox2b causes lack of CO2 chemosensitivity, fatal central apnea, and specific loss of parafacial neuronsVéronique Dubreuil, Nélina Ramanantsoa, Delphine Trochet, et al.
Pageof 3